Skip to main content

Showing results for Diabetes

IU School of Medicine leading national study to treat diabetic foot wounds, decrease amputation rates

Indiana University School of Medicine is leading the first study of the national Diabetic Foot Consortium with the goal of preventing reopening of closed wounds by identifying a biomarker that would predict such recurrence during the process of standard wound care.

IU School of Medicine  |  Jul 24, 2020

Diabetes center recognizes scientists for promising projects

The Center for Diabetes and Metabolic Diseases (CDMD) at Indiana University School of Medicine has recognized six Indiana scientists for their innovative projects.

IU School of Medicine  |  Jun 18, 2020

Evans-Molina named director of diabetes research center

INDIANAPOLIS—Carmella Evans-Molina, MD, PhD, has been appointed director of the Center for Diabetes and Metabolic Diseases (CDMD) at Indiana University School of Medicine. Evans-Molina is the center’s second appointed director since it received designation from the National Institutes of Health in 2015. The center’s mission is to bring cutting-edge research tools to diabetes investigators at […]

IU School of Medicine  |  Oct 08, 2019

Funding to help researchers study link between high blood sugar, cancer

It is well understood that people with diabetes have an increased risk for a number of other health complications—including cancer. Last year, when Indiana University School of Medicine researchers demonstrated that inflammation can increase risk for leukemia, they wondered if it was also the culprit that placed people with diabetes at a higher risk for […]

IU School of Medicine  |  Jun 14, 2019

Study based at Indiana University School of Medicine finds improvements in insulin production wane after treatment stops in adults with early type 2 diabetes

A set of clinical trials examining youth and adults with type 2 diabetes or impaired glucose tolerance has found that disease progression in adults slowed during medical treatment but resumed after treatment stopped. Youth on the same treatment had markedly poorer outcomes with continued disease progression both during and after the treatment. This research, funded […]

Christina Griffiths  |  Jun 10, 2019

Immunotherapy delays Type 1 diabetes diagnosis in people at high risk

Presented on June 9 in San Francisco at the 2019 American Diabetes Association’s 79th Scientific Sessions and published in the New England Journal of Medicine, findings from TrialNet’s Teplizumab (anti-CD3) Prevention Study show a drug that targets the immune system can delay Type 1 diabetes a median of 2 years in children and adults at […]

IU School of Medicine  |  Jun 09, 2019

IU announces progress toward its Precision Health Grand Challenge: cancers it aims to cure, diseases it is working to prevent

Indiana University researchers and physicians announced progress toward their bold goals of developing cures and preventive treatments for devastating diseases prevalent among Indiana residents.

IU School of Medicine  |  Aug 06, 2018

IU School of Medicine researcher awarded $1.9 million grant to study vision-threatening condition

Indiana University School of Medicine was recently awarded a five-year, $1.9 million grant by to study diabetic retinopathy, a long-term, vision-threatening complication of diabetes.

IU School of Medicine  |  Oct 24, 2017

Overall cancer risk not increased with use of popular diabetes medication, IU study finds

People taking a new oral medication for Type 2 diabetes can breathe a sigh of relief concerning suspicions they might be at an increased risk for many types of cancer, according to Indiana University researchers.

IU School of Medicine  |  Sep 21, 2017

Raghu Mirmira named director of Herman B Wells Center for Pediatric Research

Indiana University School of Medicine will continue its nationally recognized work in the scientific discovery of innovative medical treatments and care for children with the appointment of Raghu G. Mirmira, MD, PhD, as director of the school’s Herman B Wells Center for Pediatric Research, which is associated with Riley Hospital for Children at IU Health.

IU School of Medicine  |  Jul 19, 2017